Point72 Asset Management L.P. Has $45.85 Million Stock Holdings in Sanofi (NASDAQ:SNY)

Point72 Asset Management L.P. boosted its holdings in Sanofi (NASDAQ:SNY - Free Report) by 969.6% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 950,649 shares of the company's stock after buying an additional 861,770 shares during the period. Point72 Asset Management L.P.'s holdings in Sanofi were worth $45,850,000 as of its most recent SEC filing.

Other large investors have also bought and sold shares of the company. Synergy Asset Management LLC bought a new stake in shares of Sanofi during the 4th quarter valued at $25,000. McClarren Financial Advisors Inc. grew its stake in shares of Sanofi by 952.6% during the fourth quarter. McClarren Financial Advisors Inc. now owns 600 shares of the company's stock worth $28,000 after purchasing an additional 543 shares during the period. Lee Danner & Bass Inc. bought a new stake in Sanofi in the fourth quarter valued at about $31,000. Bessemer Group Inc. lifted its stake in Sanofi by 59.8% in the fourth quarter. Bessemer Group Inc. now owns 647 shares of the company's stock valued at $32,000 after buying an additional 242 shares during the period. Finally, Sierra Ocean LLC acquired a new position in Sanofi in the fourth quarter valued at about $44,000. 14.04% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

SNY has been the subject of several analyst reports. Deutsche Bank Aktiengesellschaft upgraded Sanofi from a "sell" rating to a "hold" rating in a research report on Thursday, January 30th. BNP Paribas started coverage on shares of Sanofi in a report on Tuesday, April 15th. They set an "outperform" rating and a $65.00 price objective for the company. Sanford C. Bernstein raised shares of Sanofi to a "strong-buy" rating in a research note on Thursday, January 30th. The Goldman Sachs Group began coverage on shares of Sanofi in a research report on Friday, March 21st. They set a "neutral" rating and a $65.00 price target on the stock. Finally, Hsbc Global Res raised shares of Sanofi to a "strong-buy" rating in a report on Monday, April 28th. Three equities research analysts have rated the stock with a hold rating, two have issued a buy rating and three have issued a strong buy rating to the stock. According to MarketBeat, the stock currently has an average rating of "Buy" and an average target price of $63.33.

Sanofi Stock Up 1.2%

Shares of SNY traded up $0.60 on Monday, hitting $52.28. The company's stock had a trading volume of 1,500,928 shares, compared to its average volume of 2,377,379. The firm's fifty day moving average price is $53.36 and its 200-day moving average price is $51.88. Sanofi has a fifty-two week low of $45.80 and a fifty-two week high of $60.12. The company has a quick ratio of 1.14, a current ratio of 1.46 and a debt-to-equity ratio of 0.15. The firm has a market capitalization of $132.07 billion, a price-to-earnings ratio of 21.00, a P/E/G ratio of 1.01 and a beta of 0.55.

Sanofi (NASDAQ:SNY - Get Free Report) last released its quarterly earnings results on Thursday, April 24th. The company reported $0.94 earnings per share for the quarter, beating the consensus estimate of $0.90 by $0.04. Sanofi had a net margin of 12.77% and a return on equity of 25.61%. The company had revenue of $10.41 billion during the quarter, compared to analysts' expectations of $9.79 billion. During the same quarter in the prior year, the company earned $1.78 earnings per share. The business's quarterly revenue was down 11.0% compared to the same quarter last year. On average, equities research analysts expect that Sanofi will post 4.36 EPS for the current year.

Sanofi Increases Dividend

The business also recently announced an annual dividend, which will be paid on Thursday, June 12th. Investors of record on Friday, May 9th will be paid a $2.0369 dividend. The ex-dividend date of this dividend is Friday, May 9th. This is a positive change from Sanofi's previous annual dividend of $1.48. This represents a yield of 3.1%. Sanofi's dividend payout ratio is presently 57.14%.

About Sanofi

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.